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CCAAT/enhancer-binding protein (C/EBP) basic region/leucine zipper (bZIP) transcription factors have been shown to form heterodimers with
cAMP-responsive element binding protein 2 (CREB-2), a transcription factor involved in regulating basal and Tax-mediated transactivation of the
human T cell leukemia virus type 1 (HTLV-1) long terminal repeat (LTR). In cells of the monocyte–macrophage lineage (proposed to play a role in
HTLV-1 pathogenesis as an accessory target cell), several members of the C/EBP family are expressed at high levels and may have functional
impact on both basal and Tax-mediated transactivation of the HTLV-1 LTR. Basal activation of the HTLV-1 LTR was enhanced by overexpression
of C/EBPβ, C/EBPδ, or C/EBPε, whereas transactivation of the LTR by Tax was inhibited by overexpression of C/EBPα and C/EBPβ. Inhibition
of Tax-mediated transactivation of the HTLV-1 LTR was co-activator-independent, did not require C/EBP binding to the Tax-responsive elements,
and may involve heterodimerization with CREB factors.
© 2006 Elsevier Inc. All rights reserved.Keywords: HTLV-1; Tax; CCAAT/enhancer-binding protein; Long terminal repeat; HAM/TSP; Monocyte–macrophageIntroduction
Human T cell leukemia virus type 1 (HTLV-1) is the
etiological agent of adult T cell leukemia (ATL) and HTLV-1-
associated myelopathy, also referred to as tropical spastic
paraparesis (HAM/TSP) (Gessain et al., 1985; Grant et al.,
2002; Osame et al., 1986; Poiesz et al., 1980; Wigdahl and
Brady, 1996; Yao and Wigdahl, 2000; Yoshida et al., 1982).
However, only ∼5% of individuals infected with HTLV-1
develop ATL or HAM/TSP, while ∼95% remain healthy⁎ Corresponding author. Department of Microbiology and Immunology,
Center for Molecular Virology and Neuroimmunology, Center for Cancer
Biology, Drexel University College of Medicine, 2900 W. Queen Lane,
Philadelphia, PA 19129, USA. Fax: +1 215 848 2271.
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doi:10.1016/j.virol.2005.12.024carriers. It has been reported that the proviral DNA and viral
RNA loads are critical factors in promoting disease progression
in infected individuals (Kubota et al., 1994; Manns et al., 1999;
Nagai et al., 1998; Yamano et al., 2001). Viral gene expression
from an integrated provirus is regulated at the transcriptional
level by interaction of numerous cellular transcription factors
with the HTLV-1 long terminal repeat (LTR), including
activating transcription factor 1 (ATF-1), ATF-2, cAMP-
responsive element binding protein 1 (CREB-1), CREB-2
(also known as ATF-4), cAMP-responsive element modulator
protein (CREM), activator protein 1 (AP-1), AP-2, c-Ets, c-
Myb, Gli-2, Sp1, and Sp3 (Barnhart et al., 1997; Bosselut et al.,
1990, 1992; Dan et al., 1999; Franklin et al., 1993; Gachon et
al., 1998, 2000; Laurance et al., 1997; Livengood and Nyborg,
2004; Muchardt et al., 1992; Tillmann et al., 1994; Wessner and
Wigdahl, 1997; Wessner et al., 1995, 1997; Zhao and Giam,
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binding protein (CBP)/p300, have been shown to regulate basal
viral gene expression (Lenzmeier et al., 1998; Nyborg and
Dynan, 1990; Nyborg et al., 1988). Accumulation of the viral
oncoprotein Tax within infected cells and subsequent nuclear
localization have been shown to result in transactivation of viral
gene expression by Tax through direct interactions with the
basic region and leucine zipper of ATF/CREB factors, which
leads to the stabilization of ATF/CREB dimers and enhanced
DNA-binding activity of the ATF/CREB-Tax complex to Tax-
responsive element 1 (TRE-1) 21-bp repeats (Yin et al., 1995a).
Each TRE-1 repeat consists of a core cAMP-responsive element
(CRE), which has been shown to facilitate binding of ATF/
CREB factors that also involves interactions with the flanking
GC-rich sequences. Tax makes direct contacts with these GC-
rich sequences, thus stabilizing ATF/CREB-Tax complexes on
the viral promoter (Kimzey and Dynan, 1998; Lenzmeier et al.,
1998). Tax recruits CBP/p300 to the viral promoter, and the
intrinsic histone acetyltransferase activity of CBP/p300 facil-
itates localized nucleosomal histone acetylation and remodeling
of the chromatin environment, resulting in recruitment of RNA
polymerase II and general transcription factors (Lemasson et al.,
2002; Lu et al., 2002). This sequence of events, precipitated by
Tax, has been shown to coordinate high-level viral gene
expression.
Viral gene expression from an integrated provirus represents
a critical stage in the life cycle of a retrovirus as the virus must
depend on the expression and activation of specific cellular
transcriptional regulators to initiate and maintain a productive
infection. Many transcription factors are regulated by the cell
during differentiation and/or activation at one or more levels
(e.g., transcription, post-translational modification, subcellular
localization, DNA-binding activity, activation potential, and
degradation). Furthermore, expression of many transcriptional
regulators is cell type- and differentiation stage-specific (Ramji
and Foka, 2002; Rohr et al., 2003; Valledor et al., 1998).
Therefore, we have hypothesized that a number of factors
influence HTLV-1 viral gene expression, including: (1) the cell
lineage infected; (2) the stage of differentiation of the infected
cell; and (3) whether the infected cell is resting or activated. The
most well-characterized cellular target for HTLV-1 is the CD4+
T lymphocyte as these cells represent the predominant viral
reservoir within infected individuals (Newbound et al., 1996).
However, more recently, HTLV-1 has also been shown to infect
CD8+ T cells, B cells, monocytes, dendritic cells, astrocytes,
and bone marrow progenitor cells in vivo, although these cell
populations appear to be less permissive with respect to HTLV-
1 viral gene expression and virus production (Koyanagi et al.,
1993; Lehky et al., 1995; Nagai et al., 2001). Interestingly, very
little information exists concerning the molecular mechanisms
regulating HTLV-1 LTR activation in these pathogenically
relevant secondary target cell populations.
CCAAT/enhancer-binding proteins (C/EBPs) are a family
of cellular bZIP transcription factors (designated C/EBPα, C/
EBPβ, C/EBPγ, C/EBPδ, C/EBPε, and C/EBPζ) that all
share a highly conserved basic region (responsible for nuclear
localization and DNA-binding activity) and leucine zipper(required for formation of homodimers and heterodimers)
located at the C-terminus. The N-terminal and central regions
of C/EBPs, which consist of modular transactivation and
regulatory domains, are less conserved (Ramji and Foka,
2002). Several C/EBP factors, including C/EBPα, C/EBPβ,
and C/EBPε, are expressed not only as full-length proteins,
but also as truncated isoforms, sometimes with greatly diverse
functional properties (Descombes and Schibler, 1991; Ossi-
pow et al., 1993). C/EBPs contain many domains that are
highly conserved between rodents and humans (Williams et
al., 1998), suggesting that they perform many of the same
functions in different species. Transcription factors within the
C/EBP family are involved in the regulation of proliferation,
differentiation, metabolism, and inflammation within numer-
ous cell types (e.g., adipocytes, hepatocytes, granulocytes,
and monocytes). Furthermore, C/EBP factors are themselves
regulated during cellular differentiation and activation. Recent
studies have demonstrated that C/EBPs interact with a
number of other transcriptional regulators (e.g., CREB-2,
NF-κB, Sp1, c-Ets) and co-activator proteins (CBP and p300)
(Lopez-Rodriguez et al., 1997; Mink et al., 1997; Nagulapalli
et al., 1995; Newman and Keating, 2003; Schwartz et al.,
2000; Stein et al., 1993). The interaction between C/EBP and
CREB-2 involves the formation of heterodimers via the
leucine zipper of each protein (Newman and Keating, 2003),
and certain C/EBP family members appear to exhibit greater
affinity with respect to forming heterodimers with CREB-2
than others. C/EBP-responsive target genes include proin-
flammatory cytokines interleukin 1 beta (IL-1β), IL-6, and
tumor necrosis factor alpha (TNF-α), among many others
(Ramji and Foka, 2002). Interestingly, Tax has been shown to
enhance sequence-specific binding of C/EBP to cellular
promoters (e.g., IL-1β, IL-4, and IL-5) and a C/EBP
consensus sequence (Li-Weber et al., 2001a, 2001b; Tsukada
et al., 1997; Wagner and Green, 1993).
In this study, we report for the first time that multiple
members of the C/EBP family, when overexpressed in Jurkat
T cells (a model cell line for the primary target of HTLV-1,
CD4+ T cells) and U-937 monocytic cells (a model cell line
for an accessory target of HTLV-1, monocytes), differentially
regulate basal and Tax-mediated transactivation of HTLV-1
viral gene expression. First, we demonstrate that expression of
C/EBPβ, C/EBPδ, or C/EBPε in transient expression analyses
resulted in modest up-regulation of basal LTR activation.
Second, we provide evidence demonstrating that expression
of C/EBPα or C/EBPβ (including the truncated C/EBPβ
isoforms LAP and LIP) resulted in sharply reduced levels of
Tax-mediated LTR transactivation, while C/EBPδ only
moderately inhibited Tax-mediated transactivation of the
LTR. Subsequent studies concerning the mechanism of C/
EBPβ (the most widely studied C/EBP factor) inhibition of
Tax-induced transactivation of the HTLV-1 LTR demonstrated
that, although binding of several C/EBP isoforms to TRE-1
repeat III and TRE-2 were detected by electrophoretic
mobility shift (EMS) analyses utilizing U-937 monocytic
nuclear extracts, C/EBPβ interaction with these sites was not
required to inhibit Tax-mediated transactivation. Furthermore,
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required to inhibit Tax-mediated transactivation of the HTLV-
1 LTR. However, the C-terminal leucine zipper dimerization
domain and basic region DNA-binding domain of C/EBPβ
were crucial for inhibiting Tax-mediated transactivation of the
HTLV-1 viral promoter. Deletion of the C/EBPβ leucine
zipper or basic region abrogated the inhibitory effect of C/
EBPβ with respect to Tax-mediated transactivation of the
HTLV-1 LTR. Collectively, these results have suggested that
C/EBP factors promote a low level of viral gene expression in
the absence of Tax, while inhibiting high-level viral gene
expression in the presence of Tax. The effects of exogenous
C/EBP expression were similar in both U-937 cells (which
exhibit relatively high levels of C/EBP DNA-binding activity)
and Jurkat cells (which exhibit low to undetectable levels of
C/EBP DNA-binding activity) (Li-Weber et al., 2001a,
2001b) Grant and Wigdahl, unpublished observations). In
addition, differential inhibition by different members of the C/
EBP family suggests the potential for regulation of HTLV-1
LTR activation within different cell populations based on the
endogenous expression levels of C/EBP factors during either
differentiation and/or activation.
Results
Overexpression of specific C/EBP isoforms differentially
regulates transcriptional activation of the HTLV-1 LTR
The HTLV-1-encoded transactivator protein Tax is known to
interact with a number of intracellular proteins, including bZIP
transcription factors. Tax interaction with ATF/CREB proteins,
such as CREB-2, leads to enhanced dimerization and,
subsequently, enhanced DNA-binding activity to the Tax-
responsive element 1 (TRE-1) 21-bp repeats of the HTLV-1
LTR (Franklin et al., 1993; Marriott et al., 1990; Zhao and Giam,
1992). Enhanced ATF/CREB DNA-binding activity involves
direct interactions between ATF/CREB and the core viral
cAMP-responsive element (viral CRE) located in the center of
each TRE-1 21-bp repeat and direct interactions between Tax
and G/C-rich sequences flanking the core viral CRE (Lenzmeier
et al., 1998). The DNA-binding activity of other cellular
transcription factors (e.g., Sp1, AP-1, and C/EBP) to their
consensus binding sites has also been shown to be enhanced in
the presence of Tax (Wagner and Green, 1993; Yin et al., 1995a).
Recent reports have suggested that C/EBP factors may interact
with CREB-2 in vitro and in vivo by forming heterodimers
(Gachon et al., 2001; Hivin et al., 2004; Newman and Keating,
2003) and that these heterodimers preferentially recognize CREs
rather than CCAAT boxes (Podust et al., 2001). Previously,
heterodimerization between CREB-2 and the C/EBPζ (also
known as CHOP) has been shown to repress Tax-mediated
transactivation of a synthetic HTLV-1 promoter element
containing three tandem copies of TRE-1 repeat III (Gachon et
al., 2001). Since the leucine zipper dimerization domain of C/
EBPζ was required for inhibition and the C-terminal bZIP
domains of C/EBP family proteins are highly conserved, we
hypothesized that additional members of the C/EBP familycould regulate Tax-mediated transactivation of the full-length
HTLV-1 LTR by similar mechanisms.
C/EBPα, C/EBPβ, C/EBPδ, and C/EBPε are expressed
predominantly in cells of the monocyte–macrophage lineage
and have been implicated in regulating cell type- and
differentiation stage-specific gene expression (Lekstrom-
Himes and Xanthopoulos, 1998; Ramji and Foka, 2002).
These C/EBP factors function as activators of transcription of
numerous C/EBP-responsive promoters (Ramji and Foka,
2002), including the herpes simplex virus thymidine kinase
promoter (Figs. 1A and B), which is commonly used as an
internal reference reporter in the form of pRL-TK. In addition,
responsiveness of commonly used internal control plasmids to
co-transfected viral transcriptional regulators (e.g., HTLV-1 Tax
and adenovirus E1A) has been widely reported (Kubota et al.,
2001; Tabakin-Fix et al., 2004; Thavathiru and Das, 2001).
Therefore, to prevent misinterpretation of transcriptional
analysis data caused by co-transfected transcriptional regulators
affecting expression of the internal reference reporter, normal-
ization of luciferase activity to an internal control plasmid was
not performed in this study. To determine whether these C/EBP
factors could also play a role in regulating HTLV-1 viral gene
expression, transient expression analyses were performed by co-
transfecting an HTLV-1 LTR luciferase reporter vector (pU3R-
luc) in the absence or presence of an empty expression vector
(pCMV4) or expression vectors encoding HTLV-1 Tax, C/
EBPα, C/EBPβ, C/EBPδ, or C/EBPε into U-937 monocytic
cells (Fig. 1C) or Jurkat CD4+ T cells (Fig. 1D). Basal LTR
activation was significantly enhanced by overexpression of C/
EBPβ, C/EBPδ, and C/EBPε, but not by C/EBPα. However,
overexpression of C/EBPα and C/EBPβ resulted in a clear and
dramatic decrease in Tax-mediated transactivation of the HTLV-
1 LTR. C/EBPδ inhibited Tax-mediated transactivation to a
lesser extent, while C/EBPε did not have a significant effect on
transactivation. C/EBPα and C/EBPβ overexpression did not
positively or negatively affect the expression of HTLV-1 Tax as
determined by western immunoblot analysis (Fig. 1E). These
results have suggested that C/EBPα, C/EBPβ, and C/EBPδ
inhibit Tax-mediated transactivation by specifically disrupting
the mechanism(s) employed by Tax to transactivate the LTR.
These results expand upon the results of Gachon et al. (2001) and
Hivin et al. (2004) by demonstrating that multiple C/EBP factors
in addition to C/EBPβ and C/EBPζ are capable of regulating not
only Tax-dependent, but also Tax-independent HTLV-1 gene
expression in a model cell of pathogenic relevance to HTLV-1-
induced disease.
C/EBPβ is expressed endogenously as a full-length 39-kDa
protein, a 36-kDa protein (referred to as liver-enriched
transcriptional activator protein or LAP), and a 20-kDa protein
(referred to as liver-enriched transcriptional inhibitory protein or
LIP) (Ossipow et al., 1993) (Fig. 2A). LAP and LIP are
synthesized as the result of internal translation initiation events
from a single mRNA (Descombes and Schibler, 1991). Although
full-length C/EBPβ and LAP function as activators of
transcription, LIP functions as a repressor of transcription by
forming heterodimers with other C/EBP proteins. Subsequent
DNA-binding of LIP-containing heterodimers is thought to
Fig. 1. Specific C/EBP isoforms inhibit Tax-mediated transactivation of the HTLV-1 LTR. (A) Schematic of C/EBPα, C/EBPβ, C/EBPδ, and C/EBPε. (B and C) U-937
monocytic cells or (D) Jurkat CD4+ Tcells (1 × 106) were transiently transfectedwith a C/EBP-responsive luciferase reporter vector (pRL-TK; 50 ng) or anHTLV-1 LTR
luciferase reporter construct (pU3R-luc; 200 ng) in the absence or presence of an expression vector encoding Tax (pCMV-Tax; 200 ng), an empty expression vector
(pCMV4; 500 ng), or expression vectors encoding parental C/EBP family members (pCMV-C/EBPα, pCMV-C/EBPβ, pCMV-C/EBPδ, or pCMV-C/EBPε; 500 ng).
Relative luciferase activity was quantitated 24 h post-transfection and normalized so that pU3R-luc activity in the absence of any additional expression vectors is equal to
1.0. The values shown in (B), (C), and (D) representmean± standard deviation. Expression ofC/EBPα, C/EBPβ, C/EBPδ, and/orC/EBPε significantly (*Pb 0.05 versus
negative controls) affected transcriptional activation of the C/EBP-responsive promoter and HTLV-1 LTR. (E)Western immunoblot analysis of HTLV-1 Tax expression
in U-937 (1 × 106) transfected with pCMV4, pCMV-Tax, and/or pCMV-C/EBPβ and/or pCMV-C/EBPα (1 μg each). The dots pinpoint the 40 kDa Tax protein.
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Fig. 2. C/EBPβ isoforms LAP and LIP inhibit Tax-mediated transactivation of the HTLV-1 LTR. (A) Schematic of C/EBPβ isoforms. (B and C) U-937 monocytic cells
or (D) Jurkat CD4+ T cells (1 × 106) were transiently transfected with a C/EBP-responsive luciferase reporter vector (pC/EBP3x-luc; 200 ng) or an HTLV-1 LTR
luciferase reporter construct (pU3R-luc; 200 ng) in the absence or presence of an expression vector encoding Tax (pCMV-Tax; 200 ng), an empty expression vector
(pCMV4; 500 ng), or expression vectors encoding C/EBPβ LAP or LIP (pSCT-LAP and pSCT-LIP; 500 ng). Relative luciferase activity was quantitated 24 h post-
transfection and normalized to basal pU3R-luc. The values shown in (B), (C), and (D) represent mean ± standard deviation. Expression of C/EBPβ isoforms LAP and/
or LIP significantly (*P b 0.05 versus negative controls) affected transcriptional activation of the C/EBP-responsive promoter and HTLV-1 LTR.
358 C. Grant et al. / Virology 348 (2006) 354–369prevent recruitment of co-activators since LIP is hypothesized to
be unable to bind to CBP/p300 (Lee et al., 2002), thus inhibiting
transcriptional activation by preventing localized histone
acetylation and recruitment of RNA polymerase II and general
transcription factors (Lu et al., 2002). As demonstrated in Fig.
2B, overexpression of C/EBPβ (LAP) stimulated transcriptionalactivation of a synthetic promoter containing three tandem
copies of a C/EBP consensus binding site (pC/EBP3x-luc).
However, the effect of C/EBPβ LIP alone on the C/EBP reporter
is likely masked due to the expression of endogenous C/EBPβ
LAP in U-937 cells. C/EBPβ LIP does indeed suppress
activation of pC/EBP3x-luc. This is most evident in dose–
359C. Grant et al. / Virology 348 (2006) 354–369response analyses where the amount of C/EBPβ LAP is held
constant while the amount of C/EBPβ LIP is increased (data not
shown).
The basal activation of the HTLV-1 LTR was significantly
enhanced by overexpression of C/EBPβ (LAP not LIP) in
Jurkat T cells but not in U-937 cells, while the overexpression of
both C/EBPβ isoforms in U-937 and Jurkat cells resulted in a
profound down-regulation of Tax-mediated transactivation of
the HTLV-1 LTR (Figs. 2C and D). This could be explained by
differential protein expression of various C/EBP isoforms in the
two cell types. U-937 cells have been shown to express
relatively high levels of both C/EBPα and C/EBPβ, and C/
EBPβ LIP by western immunoblot analyses (Natsuka et al.,
1992; Henderson and Calame, 1997). We can detect these
proteins by EMS analyses utilizing U-937 nuclear extracts,
radiolabeled probes containing characterized C/EBP binding
sites, and polyclonal antibodies specific for individual C/EBP
family members (Quiterio et al., 2003). Jurkat T cells also have
been shown by western immunoblot analyses to express C/
EBPα, C/EBPβ, and C/EBPδ, but not C/EBPβ LIP. However,
while nuclear C/EBP protein levels are very abundant in U-937
cells, nuclear C/EBP protein levels are low to undetectable in
Jurkat T cells or HTLV-1-infected T cells (e.g., SLB-1 or
C8166) in gel shift analyses (Li-Weber et al., 2001a, 2001b;
Grant and Wigdahl, unpublished observations). Together,
evidences from the literature as well as our own studies have
suggested that, while C/EBP protein expression in U-937 and
Jurkat cells may be equivalent, nuclear C/EBP protein
accumulation may be much greater in U-937 cells compared
to Jurkat T cells. Post-translational modifications of nuclear C/
EBP forms may also play a role in regulating nuclear
localization and/or DNA-binding activity. The observation
that LIP, a C/EBPβ isoform missing most of the N-terminal
transactivation domain, inhibited LTR activation in the presence
of Tax to the same extent as LAP or full-length C/EBPβ has
suggested that sequences within the N-terminal transactivation
domain were not required for mediating this inhibitory effect.
These results demonstrate that each of the naturally occurring
isoforms of C/EBPβ is capable of repressing Tax transactivation
of the LTR while exhibiting unique characteristics for
stimulating basal LTR activation.
Competition between Tax and C/EBP for binding to p300 is not
required for C/EBP-mediated inhibition of Tax-mediated LTR
transactivation
Although the results shown in Figs. 1 and 2 demonstrate that
C/EBP down-regulates HTLV-1 LTR transactivation by Tax, a
number of mechanisms may be operative, such as (1)
competition between C/EBP and Tax for recruitment of co-
activators CBP/p300 to the viral promoter; (2) C/EBP binding
directly to the viral promoter in such a manner as to prevent
another cellular or viral protein from binding; and/or (3) direct
interaction between C/EBP and Tax and/or C/EBP and ATF/
CREB in such a manner as to prevent a function of Tax and/or
ATF/CREB critical for LTR activation. Co-activator competi-
tion has been demonstrated to occur between Tax and cellular(c-Jun or c-Myb) or viral (HTLV-1 p30II) factors, which
recognize and bind to overlapping regions within the KIX
domain of CBP/p300 (Colgin and Nyborg, 1998; Van Orden et
al., 1999; Yan et al., 1998; Zhang et al., 2001). Although C/
EBPβ has been shown to interact with the C/H3 domain (also
known as the E1A binding domain, see Fig. 3A) of CBP/p300
(Kovacs et al., 2003; Mink et al., 1997), such an interaction may
be capable of inhibiting Tax-mediated transactivation, perhaps
by inducing a conformational change in CBP/p300 and/or
inducing phosphorylation of CBP/p300.
To determine whether competition between C/EBP and Tax
for CBP/p300 was required for C/EBP-mediated inhibition,
transient expression analyses in U-937 cells were performed by
co-transfection with a pU3R-luc reporter vector in the absence
or presence of expression vectors encoding C/EBPβ, adenovi-
rus E1A, and/or p300. Previous investigations have shown that
C/EBPβ binding to CBP and p300 via the C/H3 or E1A binding
domain and recruitment of CBP/p300 to C/EBP-responsive
promoters can be blocked by overexpression of E1A (Mink et
al., 1997). Furthermore, inhibition of C/EBP target gene
expression by E1A can be rescued by overexpression of CBP
or p300 (Mink et al., 1997). These effects were confirmed by
transient expression analysis in U-937 cells utilizing a luciferase
reporter vector driven by three tandem copies of a consensus C/
EBP-responsive element (pC/EBPx3-luc) (Fig. 3B). C/EBP-
mediated inhibition of Tax-mediated transactivation of the
HTLV-1 LTR was examined by co-transfecting the HTLV-1
LTR luciferase reporter vector in the absence or presence of Tax,
LAP, E1A, and p300. The results presented in Fig. 3C
demonstrate that C/EBP-mediated inhibition of HTLV-1 LTR
transactivation by Tax was not affected by blocking p300
binding to C/EBP with E1A overexpression. Expression of E1A
did not significantly affect Tax-mediated transactivation of the
LTR (data not shown). In addition, overexpression of p300 was
unable to rescue Tax-mediated transactivation of the HTLV-1
LTR in the presence of LAP. Together, these results suggest that
C/EBP and Tax do not compete for CBP/p300 and that C/EBP
binding to these co-activators was not involved in C/EBP-
mediated inhibition of HTLV-1 viral gene expression in the
presence of Tax. The observation that LIP (which is missing the
N-terminal transactivation domain required for functionally
interacting with CBP/p300; Kovacs et al., 2003) was also able
to inhibit Tax-mediated transactivation of the HTLV-1 LTR
(Fig. 2) further supported these observations.
Monocyte-specific binding of C/EBP factors to TRE-1 repeat
III and TRE-2
Previous studies have indicated that C/EBP factors interact
directly with cis-acting promoter elements containing CCAAT
boxes (reviewed in Ramji and Foka, 2002). In addition, through
the formation of heterodimers with CREB-2, C/EBP factors
may also directly interact with CRE-containing promoter
elements (Podust et al., 2001). To directly examine whether
C/EBP proteins physically interacted with the Tax-responsive
elements of the HTLV-1 LTR (where each of the TRE-1 21-bp
repeats contains a viral CRE), EMS supershift analyses were
Fig. 4. C/EBP proteins directly interact with the Tax-responsive elements of the HTLV-1 LTR. EMS analyses were performed by reacting U-937 monocytic nuclear
extracts with radiolabeled, double-stranded oligonucleotides corresponding to the TRE-1 repeat I, TRE-1 repeat II, TRE-1 repeat III, or TRE-2 for 30 min at 30 °C.
Control serum (CS) or polyclonal antibody specific for individual members of the C/EBP family (α, β, γ, δ, or ε) was added to the appropriate reactions during the
final 15 min of incubation. DNA–protein complex-containing reactions were then subjected to electrophoresis through a 5% polyacrylamide gel at 200 V for
approximately 2 h and detected by autoradiography.
Fig. 3. Competition for co-activator recruitment is not involved in C/EBP-mediated inhibition. (A) Schematic map of CBP/p300 including known binding sites for
viral and cellular transcriptional regulators (Blobel, 2000; Vo and Goodman, 2001). (B) U-937 cells (1 × 106) were transiently transfected with a C/EBP-responsive
luciferase reporter construct driven by the herpes simplex virus thymidine kinase promoter (pRL-TK; 50 ng) in the absence or presence of expression vectors encoding
C/EBPβ LAP (pSCT-LAP; 500 ng), adenovirus E1A (pCMV-E1A; 500 ng), and/or the co-activator p300 (pCMV-p300; 1000 ng). (C) U-937 cells (1 × 106) were
transiently transfected with an HTLV-1 LTR luciferase reporter construct (pU3R-luc; 200 ng) in the absence or presence of expression vectors encoding Tax (pCMV-
Tax; 200 ng), C/EBPβ LAP (pSCT-LAP; 500 ng), E1A (pCMV-E1A; 500 ng), and/or p300 (pCMV-p300; 1000 ng). Relative luciferase activity was quantitated 24
h post-transfection and normalized to basal pU3R-luc. The values shown in (B) and (C) represent mean ± standard deviation.
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with radiolabeled oligonucleotide probes corresponding to
TRE-1 repeat I, TRE-1 repeat II, TRE-1 repeat III, or TRE-2,
and polyclonal antibodies specific for individual C/EBP family
members. The results in Fig. 4 demonstrate that C/EBPα, C/
EBPβ, and C/EBPε form specific DNA–protein complexes
with TRE-1 repeat III, while C/EBPγ forms a specific DNA–
protein complex with TRE-2. These C/EBP-specific complexes
were detected with monocyte-derived nuclear extracts, but not
nuclear extracts derived from Jurkat CD4+ T cells (data not
shown). Due to the highly conserved nature of the C/EBP DNA-
binding domain, other C/EBP family members may also be able
to interact with these sequences (with the exception of C/EBPζ,
which has been shown to contain two proline residues within
the DNA-binding domain). In addition, the relative amounts of
C/EBP factors expressed in the nucleus may have to compete
with other transcription factors for binding to these sequences.
These results, however, cannot distinguish between binding of
C/EBP homodimers, C/EBP heterodimers, or C/EBP-ATF/
CREB heterodimers to the TRE-1 repeat III. As discussed
previously, U-937 cells have been shown to express relatively
high levels of most members of the C/EBP family of
transcription factors (Henderson and Calame, 1997; Natsuka
et al., 1992). We can detect these proteins by EMS analyses
utilizing U-937 nuclear extracts, radiolabeled probes containing
characterized C/EBP binding sites, and polyclonal antibodies
specific for individual C/EBP family members (Quiterio et al.,
2003). Intriguingly, no C/EBP binding to the TRE-1 repeats I or
II was detected. To explain this observation, it is possible that
specific non-conserved sequences present within the TRE-1
repeat III facilitate C/EBP binding to this 21-bp repeat element
and not others. With respect to TRE-2, the results in Fig. 4
suggest the presence of C/EBP homodimers or heterodimers
since no ATF/CREB binding sites have been reported within
this region of the viral promoter. Interactions between C/EBP
and additional cellular factors (e.g., Sp1 or Sp3) that bind to the
TRE-1 repeat III and TRE-2 may play a role in the recruitment
of C/EBP to these elements within the viral promoter.
Interactions between C/EBP and Tax-responsive elements are
not required for C/EBP to inhibit Tax-mediated transactivation
of the HTLV-1 LTR
To determine whether recruitment of C/EBP factors to
TRE-1 repeat III and/or TRE-2 was required to inhibit Tax-
mediated transactivation of the HTLV-1 LTR, site-directed
mutagenesis was used to delete specific regions within the
viral promoter corresponding to TRE-1 repeat I (pU3RΔI-
luc), TRE-1 repeat II (pU3RΔII-luc), TRE-1 repeat III
(pU3RΔIII-luc), and TRE-2 (pU3RΔTRE-2-luc) (Fig. 5A).
As previously described, only single TRE-1 21-bp repeat
deletion mutants were constructed because deletion of two
or more TRE-1 21-bp repeat elements rendered the HTLV-1
LTR nonresponsive to Tax (Fujisawa et al., 1986; Goren et
al., 1999). The impact of C/EBPβ on Tax-mediated
transactivation of each mutant HTLV-1 LTR luciferase
construct was examined by transient expression analyses.As shown in Fig. 5B, expression of C/EBPβ remained
capable of inhibiting Tax-mediated transactivation of the
HTLV-1 LTR even when the TRE-1 repeat III or TRE-2
was mutated. These results have suggested that, although
specific C/EBP isoforms may be able to bind to the LTR,
such interactions are not required for C/EBP to inhibit Tax-
mediated transactivation. Although these results have
excluded the possibility of interactions between C/EBP and
the Tax-responsive elements as a requirement for inhibition,
other sequences within the LTR may possibly allow C/EBP
to bind and subsequently inhibit Tax-mediated transactiva-
tion of the HTLV-1 LTR. One such C/EBP binding site was
discovered within the R/U5 region of the LTR, previously
designated as downstream regulatory element 1 (DRE-1)
(Kashanchi et al., 1994), utilizing the TRANSFAC MatIn-
spector database, and EMS supershift and competition
analyses with U-937 nuclear extracts. Site-directed muta-
genesis of this downstream C/EBP binding site (through
introduction of point mutations or deletion of the entire
site), however, was also unable to prevent C/EBP-mediated
inhibition of HTLV-1 LTR transactivation by Tax (data not
shown). These results further support that binding to the
LTR is not important for C/EBP-mediated inhibition of Tax-
dependent LTR activation.
The C-terminal leucine zipper domain and basic region are
required for C/EBP to inhibit Tax-mediated transactivation of
the HTLV-1 LTR
A recent comprehensive examination of the dimerization
properties of 62 bZIP transcription factors demonstrated that
C/EBP family members exhibit differential affinities with
respect to forming heterodimers with CREB-2 (Newman and
Keating, 2003), a key regulator of Tax-mediated HTLV-1 LTR
activation. Therefore, the interaction of C/EBP with CREB
was examined with respect to a potential role in the inhibition
of Tax-mediated transactivation. To this end, transient
expression analyses were performed utilizing expression
vectors encoding a parental C/EBPβ protein or a C/EBPβ
mutant protein in which the C/EBPβ leucine zipper was
removed (Fig. 6A). Since deletion of the C/EBPζ leucine
zipper abrogated heterodimerization with CREB-2 (Gachon et
al., 2001), it was expected that the C/EBPβΔLZ mutation
would also prevent heterodimerization with CREB-2 and
possibly other ATF/CREB and/or C/EBP proteins and
therefore be unable to bind to DNA, as suggested by the
inability of C/EBPβΔLZ to activate transcription from a C/
EBP-responsive promoter (Fig. 6B). An additional C/EBPβ
mutant (C/EBPβΔBR) which lacks sequences within the
basic region required for both nuclear localization and DNA-
binding activity was used as a control since it does not
localize to the nucleus (Williams et al., 1997). As expected,
C/EBPβΔBR did not activate transcription from a C/EBP-
responsive promoter (Fig. 6B). The results in Fig. 6C clearly
demonstrated that, although parental C/EBPβ inhibited Tax-
mediated transactivation, the C/EBPβΔLZ mutant was unable
to inhibit Tax-mediated transactivation of the HTLV-1 LTR.
Fig. 5. C/EBP binding to the HTLV-1 LTR is not required for inhibition of Tax-mediated transactivation. (A) Schematic diagram of the parental HTLV-1 LTR luciferase
reporter construct and deletion mutants in which the entire TRE-1 repeat I (pU3RΔI-luc), TRE-1 repeat II (pU3RΔII-luc), TRE-1 repeat III (pU3RΔIII-luc), or TRE-2
(pU3RΔTRE-2-luc) has been completely removed by site-directed mutagenesis. (B) U-937 cells (1 × 106) were transiently transfected with either parental or mutant
HTLV-1 LTR luciferase reporter constructs (pU3R-luc, pU3RΔI-luc, pU3RΔII-luc, pU3RΔIII-luc, or pU3RΔTRE-2-luc; 200 ng) in the absence or presence of
expression vectors encoding Tax (pCMV-Tax; 200 ng) and/or C/EBPβ (pCMV-C/EBPβ; 500 ng). Relative luciferase activity was quantitated 24 h post-transfection
and normalized to basal pU3R-luc. All values in a set of experiments including basal and Tax-mediated transactivation of the HLTV-1 LTR are normalized so that
pU3R-luc activity in the absence of any additional expression vectors is equal to 1.0. The values shown in (B) represent mean ± standard deviation. Expression of C/
EBPβ significantly (*P b 0.05 versus negative controls) affected Tax-mediated transactivation of the parental and mutant HTLV-1 LTR luciferase constructs.
362 C. Grant et al. / Virology 348 (2006) 354–369These results suggested that the C/EBP leucine zipper domain
performed a critical function in repressing Tax-mediated
HTLV-1 LTR activation, possibly by promoting interaction
with members of the ATF/CREB family. Although deletion of
the C/EBPβ leucine zipper would prevent binding to the LTR,
the results shown in Fig. 5 demonstrate that this interaction
was not required to inhibit Tax-mediated transactivation of the
HTLV-1 LTR.
Discussion
This study examines, at the molecular level, the function of
C/EBP proteins with respect to regulation of the HTLV-1 LTR
activation. The key finding in this report is that multiple
members of the C/EBP family of cellular bZIP transcription
factors differentially regulate both Tax-independent and Tax-
dependent HTLV-1 gene expression. Table 1 summarizes the
results from this investigation and those from previous reports
concerning the requirements for inhibition of Tax-mediatedtransactivation of HTLV-1 viral gene expression by C/EBP
transcription factors. Our examination of the potential mecha-
nism(s) included: (1) competition between C/EBP and Tax for
recruitment of co-activators CBP/p300 to the viral promoter; (2)
C/EBP binding directly to the viral promoter in such a manner
as to prevent another cellular or viral protein from binding; and
(3) direct interaction between C/EBP and CREB or C/EBP and
Tax in such a manner as to prevent a function of CREB or Tax
critical for LTR activation. It is also possible that a common
mechanism may activate basal transcription while inhibiting
Tax-activated transcription.
These studies were performed using the U-937 promyelo-
cytic cell line that represents a well-defined model of immature
monocytic cells that can be induced to differentiate into
macrophage-like cells and express C/EBP family proteins
similar to primary human monocytes–macrophages (Natsuka et
al., 1992; Quiterio et al., 2003). In addition, U-937 cells are
adequately susceptible to most transfection techniques, making
them well suited for gene expression analyses. Although
Fig. 6. C-terminal leucine zipper and basic region of C/EBPβ are required for inhibiting Tax-mediated transactivation of the HTLV-1 LTR. (A) Schematic of parental
C/EBPβ and mutants lacking either the leucine zipper (C/EBPβΔLZ) or the basic region (C/EBPβΔBR). (B) U-937 cells (1 × 106) were transiently transfected with a
C/EBP-responsive luciferase reporter construct driven by the herpes simplex virus thymidine kinase promoter (pRL-TK; 50 ng) in the absence or presence of
expression vectors encoding parental or mutant C/EBPβ (pMEX-C/EBPβ, pMEX-C/EBPβΔLZ, or pMEX-C/EBPβΔBR; 500 ng). Relative luciferase activity was
quantitated 24 h post-transfection and normalized to basal pRL-TK. The values shown in (B) represent mean ± standard deviation. (C) U-937 cells (1 × 106) were
transiently transfected with an HTLV-1 LTR luciferase reporter construct (pU3R-luc; 200 ng) in the absence or presence of expression vectors encoding Tax (pCMV-
Tax; 200 ng) and/or parental or mutant C/EBPβ (pMEX-C/EBPβ, pMEX-C/EBPβΔLZ, or pMEX-C/EBPβΔBR; 500 ng). Relative luciferase activity was quantitated
24 h post-transfection and normalized to basal pU3R-luc. The values shown in (C) represent mean ± standard deviation.
363C. Grant et al. / Virology 348 (2006) 354–369primary human monocytes are the first choice to use for these
types of studies, these cells are very difficult to transfect at high
efficiency and viability. Binding of individual C/EBP isoforms
to specific regulatory sequences of the HTLV-1 promoter was
detected in binding assays using nuclear extracts isolated from
untransfected U-937 cells. However, only through transient
transfections of mutated and parental HTLV-1 LTR reporter
constructs into U-937 cells were we able to determine whetherTable 1
Summary of C/EBP-mediated inhibition of HTLV-1 LTR activation by Tax
Interactions Function in the
presence of Tax
LTR CREB-2 a Tax
C/EBPα + ++ N.D. Strong inhibition
C/EBPβ b + ++ + Strong inhibition
C/EBPβ LAP + ++ N.D. Strong inhibition
C/EBPβ LIP + ++ N.D. Strong inhibition
C/EBPβΔLZ − − N.D. No inhibition
C/EBPβΔBR − − N.D. No inhibition
C/EBPγ + ++ N.D. N.D.
C/EBPδ − + N.D. Moderate inhibition
C/EBPε + +/− N.D. No inhibition





a Newman and Keating (2003).
b Hivin et al. (2004).
c Gachon et al. (2001).C/EBP functioned as a repressor of LTR activation by forming
DNA–protein interactions with those sequences of the LTR.
The decision to utilize this cell line in this study was based
primarily on these characteristics. With recent advances in gene
delivery to primary cells, future studies will explore HTLV-1
LTR activation in monocytic cells of primary origin.
Our results demonstrated that blocking C/EBPβ binding to
the co-activator protein p300 or blocking C/EBPβ binding to the
HTLV-1 LTR failed to alleviate C/EBP-mediated inhibition (Fig.
3). Although C/EBPα, C/EBPβ, C/EBPγ, and C/EBPε could
physically bind to TRE-1 repeat III and TRE-2 (Fig. 4), such
DNA–protein interactions were not required to mediate
inhibition of Tax-mediated transactivation of the HTLV-1 LTR
because only C/EBPα and C/EBPβ were capable of down-
regulating Tax-dependent LTR activation (Fig. 1). The ability of
C/EBPδ to down-regulate Tax-dependent LTR activation
without physically binding to the LTR coupled with the inability
of C/EBPε to down-regulate Tax-dependent LTR activation
despite binding to the LTR exemplifies this point (see Table 1).
However, removal of the C/EBPβ leucine zipper dimerization
domain was sufficient to prevent inhibition of Tax-mediated
transactivation of the HTLV-1 LTR (Fig. 6), suggesting that C/
EBPα, C/EBPβ, and C/EBPδ may each inhibit Tax-mediated
transactivation by interacting with CREB as heterodimers. This
mechanism of inhibition is in agreement with that previously
reported by Gachon et al. (2001) for C/EBPζ, where deletion of
the C/EBPζ leucine zipper prevented its interaction with CREB-
2 and blocked inhibition of Tax-mediated transactivation.
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without interacting with Tax (Gachon et al., 2001), strengthening
the importance of C/EBP interacting with CREB-2 in suppres-
sing Tax-dependent LTR activation. Interestingly, the ability of
different C/EBP family members to inhibit Tax-mediated
transactivation of the LTR appears to directly correlate with
their affinity to heterodimerize with CREB-2, as demonstrated
by Newman and colleagues using protein–protein interaction
microarrays (Newman and Keating, 2003). Although the
interaction between C/EBPβ and Tax has not been examined
as a requirement for C/EBP-mediated inhibition in this study, the
results reported herein have suggested that eliminating the C/
EBPβ heterodimerization domain was sufficient to prevent
inhibition of Tax-mediated transactivation of the LTR (Fig. 6).
CREB, in the absence of Tax, was able to recruit co-activator
proteins CBP/p300 when phosphorylated on serine 133. This
processmay bemore readily facilitated when C/EBP proteins are
available to heterodimerize with CREB, thus resulting in
stimulation of basal activation of the HTLV-1 LTR. However,
in the presence of Tax (which recruits CBP/p300 to the viral
promoter via a KID-like domain independent of CREB
phosphorylation), C/EBP-CREB-2 heterodimers may block
the stable interaction of Tax with CREB and the viral promoter,
thus inhibiting Tax transactivation of the HTLV-1 LTR. In this
manner, it is possible for C/EBP to function as an activator of
basal LTR transcription, while still functioning as an inhibitor of
Tax-mediated LTR transcription.
The results described herein and those of Gachon et al. (2001)
contrast somewhat with more recent findings, which demon-
strated that the interaction between the central domain of C/
EBPβ and Tax, but not C/EBPβ and CREB-2, was responsible
for inhibiting Tax-mediated transactivation (Hivin et al., 2004).
However, the N-terminal and central regions are not well
conserved between C/EBP family members, suggesting that the
ability of multiple C/EBP family members (C/EBPα, C/EBPβ,
C/EBPδ, and C/EBPζ) to inhibit Tax-mediated transactivation of
the HTLV-1 LTR may not depend solely on their ability to bind
to Tax. Indeed, Mesnard and colleagues reported that, although
C/EBPζ was capable of inhibiting Tax-mediated transactivation
of the HTLV-1 LTR, C/EBPζ did not physically interact with Tax
(Gachon et al., 2001). Instead, we propose that the ability of
multiple C/EBP family members to inhibit Tax-mediated
transactivation of the HTLV-1 LTR may depend on the relative
affinity of individual C/EBP factors to form heterodimers with
CREB-2, which is mediated by the highly conserved C-terminal
leucine zipper dimerization domain. Such C/EBP-CREB-2
heterodimers may prevent Tax from binding in a conformation
permissive for LTR transactivation (e.g., binding to the LTR or
recruitment of co-activators CBP/p300) while at the same time
complementing the ability of CREB-2 to stimulate basal LTR
activation (perhaps by aiding in the recruitment of CBP/p300).
Tax-mediated transactivation of the HTLV-1 LTR is critically
dependent on the physical interactions between Tax and ATF/
CREB and Tax-mediated enhancement of ATF/CREB DNA-
binding activity to the TRE-1 21-bp repeat elements. Interaction
between Tax and ATF/CREB requires the basic region and
leucine zipper of CREB and the N- and C-terminal regions ofTax (Gachon et al., 1998, 2000; Yin et al., 1995a, 1995b).
Previous studies by Gaynor and colleagues (Yin et al., 1995a)
demonstrated that fusion proteins in which the CREB basic
region and/or leucine zipper were swapped with those from c-
Jun were unable to bind to Tax or exhibit enhanced DNA-
binding activity in the presence of Tax (Yin et al., 1995a).
Although c-Jun dimerization and DNA-binding activity have
been shown to be enhanced in the presence of Tax, Tax does not
physically interact with c-Jun (Wagner and Green, 1993; Yin et
al., 1995a). Recent studies by Mesnard and colleagues have
suggested that C/EBPβ-CREB-2 dimers may be dysfunctional
with respect to binding to Tax and recruiting Tax to the viral
promoter, even though these heterodimers retain the ability to
bind to TRE-1 repeat III (Hivin et al., 2004). Interestingly, Tax
was shown in these studies to bind to the central region of C/
EBPβ, but not the bZIP domain. Based on these observations, in
the presence of specific C/EBP family members, CREB-2 can
form heterodimers with C/EBP, and these heterodimers are thus
no longer capable of stably interacting with Tax. Therefore, we
hypothesized that, if C/EBP could be prevented from forming
heterodimers with CREB-2, or perhaps another member of the
ATF/CREB family, then C/EBP would be unable to inhibit Tax-
mediated transactivation of the HTLV-1 LTR (see Fig. 7). The
results presented in Fig. 6 and Gachon et al. (2001) support this
hypothesis.
As initiators of innate and adaptive anti-viral immune
responses, antigen-presenting cells and their precursors (in-
cluding monocytes, macrophages, and dendritic cells) play an
important role in protecting the host from infectious pathogens
(Banchereau and Steinman, 1998; Crowe et al., 2003; Randolph
et al., 1998; Santambrogio et al., 2001). C/EBPs are known to
play a critical role in the functioning of these cells during health
and times of infection. Interestingly, Tax has been shown to
enhance the DNA-binding activity of C/EBP to several cellular
promoters, but C/EBP-mediated activation appears to be down-
regulated in the presence of Tax (Grant and Wigdahl,
unpublished observations). HTLV-1-infected peripheral blood
monocytes have been detected in infected individuals, but the
level of productive infection within this cellular compartment
appears much lower than that of CD4+ T cells. Could the
relatively high levels of endogenous C/EBPs found in cells of
myeloid lineage affect the permissiveness of these cells to
support HTLV-1 viral gene expression and virus replication?
Can C/EBP expression in other cell types (e.g., CD4+ Tcells) be
modulated to repress viral gene expression? Does endogenously
or exogenously derived Tax alter the differentiation or
activation potential of macrophage and dendritic cell precursors
by inhibiting the function of C/EBP? Future investigations will
be required to elucidate the functional ramifications of the
interaction between Tax and C/EBP factors during infection of
these important cell populations. Furthermore, these investiga-
tions will be greatly facilitated by taking advantage of
transfection techniques that are capable of introducing plasmid
DNA and siRNA into primary human monocytes and dendritic
cells with both high efficiency and viability as examination of
these cell populations may reveal vital information concerning
HTLV-1 gene expression and pathogenesis. Additional studies
Fig. 7. Model of C/EBP-mediated inhibition of Tax-dependent HTLV-1 LTR transcription. In the absence of C/EBP factors, CREB-2 proteins dimerize, interact with
HTLV-1 Tax, and form Tax–CREB-2 complexes in direct contact with the Tax-responsive 21-base pair repeats of the LTR. The inhibition of Tax-mediated LTR
activation may be due to (1) reduced levels of CREB homodimers available to interact with Tax, (2) formation of CREB-C/EBP heterodimers that can complex with
Tax and prevent interaction with the LTR, and/or (3) formation of a Tax–CREB-C/EBP ternary complex that can interact with the viral LTR but fail to transactivate due
to an inability to complex the formation of a functional transcriptional complex. Blocking C/EBP dimerization by deletion of the leucine zipper motif of C/EBP
prevents C/EBP from suppressing HTLV-1 LTR activation.
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regulation of the HTLV-1 LTR within the context of the entire
genome in replication assays performed in cell lines and
primary cells of monocytic origin.
Materials and methods
Cell culture
Human promonocytic U-937 cells (ATCC, CRL-1593.2) and
Jurkat CD4+ T cells (ATCC, TIB-152) were cultured and
maintained in RPMI-1640 (Mediatech, Herndon, VA) supple-
mented with penicillin (100 U/mL), streptomycin (100 μg/mL),
sodium bicarbonate (0.15%) (Mediatech), and fetal bovine
serum (FBS; 10%) (HyClone, Logan, UT).
Nuclear extract preparation and electrophoretic mobility shift
(EMS) analyses
Small-scale nuclear extracts were prepared from low-passage,
exponentially growing cells. Briefly, cells (1 × 107) were
collected by centrifugation, washed once with 1× Dulbecco's
phosphate-buffered saline (PBS; Mediatech), and lysed in ice-
cold lysis buffer [HEPES (10 mM) pH 7.9, KCl (10 mM), EDTA
(0.1 mM), EGTA (0.1 mM), IGEPAL (0.4%), dithiothreitol(DTT; 1 mM), phenylmethylsulfonyl fluoride (PMSF; 0.5 mM),
and HALT protease inhibitor cocktail (1:100; Pierce, Rockford,
IL)]. After centrifugation (1000 × g), the supernatant (cytoplas-
mic extract) was discarded. The pelleted nuclei were gently
resuspended in nuclear extract buffer [HEPES (20 mM), NaCl
(0.4 M), EDTA (1 mM), EGTA (1 mM), DTT (1 mM), PMSF (1
mM), and HALT protease inhibitor cocktail (1:100)], shaken
vigorously for 30 min at 4 °C, and subjected to centrifugation for
10 min (16,000 × g). The supernatant (nuclear extract) was
transferred to a new eppendorf tube on ice, frozen in liquid
nitrogen, and stored at−80 °C. The protein concentration of each
sample was determined by Bradford assay as described by the
manufacturer (Bio-Rad, Hercules, CA).
The following sequences were used to generate double-stranded,
gel-purified oligonucleotides for electrophoreticmobility shift (EMS)
analysis: 5′-AGACTAAGGCTCTGACGTCTCCCCCCAGAGG-
3′ and 5′-CCTCTGGGGGGAGACGTCAGAGCCTTAGTCT-3′
(TRE-1 repeat I); 5′-CAGGCTAGGCCCTGACGTGTCCCCCT-
GAAGA-3′ and 5′-TCTTCAGGGGGACACGTCAGGGCC-
TAGCCTG-3′ (TRE-1 repeat II); 5′-GCCCTCAGGCGTTGAC-
GACAACCCC TCACCT-3′ and 5′-AGGTGAGGGGTTGTCGT-
CAACGCCTGAGGGC-3′ (TRE-1 repeat III); 5′-AGACCTC-
CGGGAAGCCACCGGGAACCACCCATTTCCTCCCC-
ATGTTT-3′ and 5′-AAACATGGGGAGGAAATGGG-TGGTTC-
CCGGTGGCTTCCCGGAGGTCT-3′ (TRE-2). The 21-bp repeat
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tides were synthesized by Integrated DNA Technologies (Coral-
ville, IA), annealed by heating at 95 °C for 5 min, and gradually
cooled to room temperature, and gel-purified. Radiolabeling of
probes was performed by an end-labeling reaction with T4 DNA
kinase (Promega, Madison, WI) and [γ-32P]ATP. Labeled probes
(75,000 cpm) were incubated in reaction buffer containing
dialysis buffer [HEPES, pH 7.9 (25 mM), glycerol (10%), KCl
(100 mM), EDTA (0.1 mM)], poly (dI–dC) (2 μg), and nuclear
extract (20 μg) for 30 min at 30 °C. DNA–protein complexes
were then resolved on a 5% polyacrylamide gel at 200 V in 1×
TBE buffer. The gels were dried under vacuum at 80 °C for 1.5
h prior to autoradiography. For supershift analysis, 2 μL of the
appropriate polyclonal antibody (Santa Cruz Biotechnologies,
Santa Cruz, CA) was added during the final 15 min of the 30 °C
incubation.
Cloning and site-directed mutagenesis
pGL3-based HTLV-1 LTR luciferase reporter vector (pU3R-
luc) was used as a template to generate mutants lacking TRE-1
repeat I (pU3RΔI-luc), TRE-1 repeat II (pU3RΔII-luc), TRE-1
repeat III (pU3RΔIII-luc), or TRE-2 (pU3RΔTRE-2-luc)
utilizing QuickChange Site-directed Mutagenesis (Stratagene,
La Jolla, CA). The following sequences were deleted from each
pU3R-luc mutant construct: −251 to −231 (ΔI); −203 to −183
(ΔII); −103 to −83 (ΔIII); and −163 to −117 (ΔTRE-2). The
deletion of individual TRE-1 21-bp repeats or TRE-2 was
confirmed by automatedDNA sequencing and sequence analysis
using Lasergene software (DNASTAR, Inc., Madison, WI).
Transient transfections
Exponentially growing U-937 or Jurkat cells were plated into
6-well tissue culture plates on the day of transfection at a
concentration of 1 × 106 cells/well. Transient transfections were
performed using the FuGene6 transfection reagent as described
by the manufacturer (Roche, Indianapolis, IN). Luciferase
reporter constructs (pU3R-luc, pU3RΔI-luc, pU3RΔII-luc,
pU3RΔIII-luc, pU3RΔTRE-2-luc, pC/EBP3x-luc, or pRL-
TK) were transfected alone or co-transfected in the absence or
presence of the appropriate expression vectors: pCMV-Tax, an
empty expression vector (pCMV4), pCMV-C/EBPα, pCMV-C/
EBPβ, pSCT-LAP, pSCT-LIP, pMEX-C/EBPβ, pMEX-C/
EBPβΔLZ, pMEX-C/EBPβΔBR, pCMV-C/EBPδ, pCMV-C/
EBPε, pCMV-E1A, and/or pCMV-p300. pU3R-luc, an HTLV-1
LTR luciferase reporter vector, was kindly provided by Kuan-
Teh Jeang (National Institutes of Health, Bethesda, MD). pC/
EBP3x-luc was purchased from Stratagene. pRL-TK was
purchased from Promega. pCMV-Tax has been described
elsewhere (Rivera-Walsh et al., 2001). pSCT-LAP, pSCT-LIP,
and pCMV-E1A were provided by Dr. Andrew Henderson
(Pennsylvania State University, University Park, PA). Expres-
sion vectors encoding C/EBPα, C/EBPβ, C/EBPδ, and C/EBPε
have been described elsewhere (Kim et al., 2002). pMEX-C/
EBPβ encodes C/EBPβ driven by the murine sarcoma virus
promoter. This vector was used to generate C/EBPβ mutantswhich harbor deletions in either the leucine zipper dimerization
domain (pMEX-C/EBPβΔLZ) or the basic region DNA-
binding domain (pMEX-C/EBPβΔBR). pCMV-p300 expres-
sion vector was purchased from Upstate Biotech (Lake Placid,
NY). The indicated amounts of pUC18 plasmid DNA were
utilized to give each reaction within an experiment an equal
amount of total DNA. Cells were harvested 24 h post-
transfection, and cell lysates were prepared using 50 μL of 1×
Passive Lysis Buffer (Promega, Madison, WI). Luciferase
activity was assayed using the Dual Luciferase Assay system
as described by the manufacturer (Promega). Normalization to
an internal control plasmid was not performed due to several
previously reported studies demonstrating the responsiveness of
widely used internal reference reporters to co-transfected
transcriptional regulators (Farr and Roman, 1991; Kubota et
al., 2001; Tabakin-Fix et al., 2004; Thavathiru and Das, 2001)
(see also Fig. 1B). Each value shown represents the average of
duplicate or triplicate transfection reactions and is representative
of at least three independent experiments. Error bars indicate the
standard deviation from one representative experiment.
Western immunoblot analysis
U-937 cells (1 × 105 cell/well) were seeded in a 12-well plates
and transfected with pCMV4, pCMV-Tax, and/or pCMV-C/
EBPβ and/or pCMV-C/EBPα (1 μg each) using Nucleofactor
Kit V as described by the manufacturer (Amaxa, Gaithersburg,
MD). After 24 h, the cell culture was collected and subjected to
centrifugation (600 × g, 5 min). The supernatant was discarded,
and the cells were washed once with ice-cold PBS (1.0 mL) and
lysed at 4 °C with shaking for 10 min using M-PER extraction
reagent supplemented with HALT protease inhibitor (Pierce).
Protein concentration was determined by Bradford assay, and 10
μg of total protein was diluted 1:2 with Laemmli Sample Buffer
(Bio-Rad, Hercules, CA). All samples were denatured at 95 °C
for 5 min and loaded onto a 12% Tris–HCl SDS polyacrylamide
gel (Bio-Rad) and subjected to electrophoresis (100 V, 3 h).
Samples were then blotted onto PVDF membrane (Immobilon-
P, Millipore Corporation, Bedford, MA) for 2 h (100 mA).
Western immunoblot analysis was performed at room temper-
ature by first blocking with 10% BSA dissolved in a solution of
phosphate-buffered saline (PBS) with 0.05% Tween-20 (PBST,
overnight) and then rinsed twice with PBST for 10 min and once
with PBS for 10 min. Blots were then incubated for 1 h with 1:50
dilution (PBST and 1% BSA) of anti-Tax monoclonal antibody
(TAB 170), provided by Dr. Fatah Kashanchi (George
Washington University, Washington DC). After primary anti-
body incubation, blots were washed as before and incubated
with a 1:50,000 dilution (PBST and 1% BSA) of Protein G–
peroxidase (Sigma, St. Louis, MO) for 1 h. After the final wash,
blots were developed using Western Lightening (Perkin Elmer
Life Sciences, Boston, MA) and exposed to X-ray film.
Statistical analysis
Data collected for transient transfections were analyzed for
statistical significance using JMP software version 5.1.1 (SAS
367C. Grant et al. / Virology 348 (2006) 354–369Institute, Cary, NC). Briefly, data sets from each experiment
were imported into JMP, and an analysis of variance (ANOVA)
was performed. The statistical significance of each data set
within an experiment was determined using the Student's t test.
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